Michael H. May - Jun 21, 2021 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Director
Signature
/s/Michael H. May
Stock symbol
AGE
Transactions as of
Jun 21, 2021
Transactions value $
$0
Form type
4
Date filed
6/23/2021, 09:46 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Option to Purchase Common Stock Award $0 +65K $0.00 65K Jun 21, 2021 Common Stock 65K $1.48 Direct F1
transaction AGE Option to Purchase Common Stock Award $0 +35K $0.00 35K Jun 21, 2021 Common Stock 35K $1.48 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options will vest and become exercisable in four equal quarterly installments on June 30, 2021, September 30, 2021, December 31, 2021, and March 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.